O-2050 is a synthetic cannabinoid derivative that functions as an antagonist at the CB1 receptor, primarily investigated for its potential therapeutic applications in managing conditions such as neuropathic… Read more
O-2050 is a synthetic cannabinoid derivative that functions as an antagonist at the CB1 receptor, primarily investigated for its potential therapeutic applications in managing conditions such as neuropathic pain and anxiety. This category includes high-quality reference standards of the O-2050 active pharmaceutical ingredient, alongside its related impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical and analytical laboratories require these precision compounds to support rigorous impurity profiling, method validation, and ongoing quality control efforts. Stable isotope-labelled versions are particularly vital as internal standards for mass spectrometry-based assays, ensuring accurate quantification and characterization of the drug substance. By utilizing these specialized reference materials, researchers can maintain compliance with regulatory standards and ensure the reliability and reproducibility of analytical data throughout the drug development and testing lifecycle.